PMID- 36882608 OWN - NLM STAT- MEDLINE DCOM- 20230510 LR - 20240502 IS - 1573-7217 (Electronic) IS - 0167-6806 (Print) IS - 0167-6806 (Linking) VI - 199 IP - 1 DP - 2023 May TI - mTOR pathway candidate genes and physical activity interaction on breast cancer risk in black women from the women's circle of health study. PG - 137-146 LID - 10.1007/s10549-023-06902-6 [doi] AB - BACKGROUND: Physical activity has been shown to affect the mammalian target of rapamycin (mTOR) signaling pathway and consequently breast carcinogenesis. Given that Black women in the USA are less physically active, it is not well understood whether there are gene-environment interactions between mTOR pathway genes and physical activity in relation to breast cancer risk in Black women. METHODS: The study included 1398 Black women (567 incident breast cancer cases and 831 controls) from the Women's Circle of Health Study (WCHS). We examined interactions between 43 candidate single-nucleotide polymorphisms (SNPs) in 20 mTOR pathway genes with levels of vigorous physical activity in relation to breast cancer risk overall and by ER-defined subtypes using Wald test with 2-way interaction term and multivariable logistic regression. RESULTS: AKT1 rs10138227 (C > T) and AKT1 rs1130214 (C > A) were only associated with a decreased risk of ER + breast cancer among women with vigorous physical activity (odds ratio [OR] = 0.15, 95% confidence interval (CI) 0.04, 0.56, for each copy of the T allele, p-interaction = 0.007 and OR = 0.51, 95% CI 0.27, 0.96, for each copy of the A allele, p-interaction = 0.045, respectively). MTOR rs2295080 (G > T) was only associated with an increased risk of ER + breast cancer among women with vigorous physical activity (OR = 2.24, 95% CI 1.16, 4.34, for each copy of the G allele; p-interaction = 0.043). EIF4E rs141689493 (G > A) was only associated with an increased risk of ER- breast cancer among women with vigorous physical activity (OR = 20.54, 95% CI 2.29, 184.17, for each copy of the A allele; p-interaction = 0.003). These interactions became non-significant after correction for multiple testing (FDR-adjusted p-value > 0.05). CONCLUSION: Our findings suggest that mTOR genetic variants may interact with physical activity in relation to breast cancer risk in Black women. Future studies should confirm these findings. CI - (c) 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. FAU - Ilozumba, Mmadili N AU - Ilozumba MN AUID- ORCID: 0000-0002-9928-3711 AD - Department of Epidemiology, University of Florida, Gainesville, FL, USA. Mmadili.Ilozumba@hci.utah.edu. AD - Department of Population Health Sciences, Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT, 84112, USA. Mmadili.Ilozumba@hci.utah.edu. FAU - Yaghjyan, Lusine AU - Yaghjyan L AD - Department of Epidemiology, University of Florida, Gainesville, FL, USA. FAU - Datta, Susmita AU - Datta S AD - Department of Biostatistics, University of Florida, Gainesville, FL, USA. FAU - Zhao, Jinying AU - Zhao J AD - Department of Epidemiology, University of Florida, Gainesville, FL, USA. FAU - Gong, Zhihong AU - Gong Z AD - Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. FAU - Hong, Chi-Chen AU - Hong CC AD - Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. FAU - Lunetta, Kathryn L AU - Lunetta KL AD - Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA. FAU - Zirpoli, Gary AU - Zirpoli G AD - Slone Epidemiology Center, Boston University, Boston, MA, USA. FAU - Bandera, Elisa V AU - Bandera EV AD - Cancer Epidemiology and Health Outcomes, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. FAU - Palmer, Julie R AU - Palmer JR AD - Slone Epidemiology Center, Boston University, Boston, MA, USA. FAU - Yao, Song AU - Yao S AD - Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. FAU - Ambrosone, Christine B AU - Ambrosone CB AD - Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. FAU - Cheng, Ting-Yuan David AU - Cheng TD AD - Department of Epidemiology, University of Florida, Gainesville, FL, USA. ting-yuan.cheng@osumc.edu. AD - Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. ting-yuan.cheng@osumc.edu. AD - Division of Cancer Prevention and Control, Department of Internal Medicine, The Ohio State University, Suite 525, 1590 North High Street, Columbus, OH, 43201, USA. ting-yuan.cheng@osumc.edu. LA - eng GR - P30 CA016056/CA/NCI NIH HHS/United States GR - P01 CA151135/CA/NCI NIH HHS/United States GR - R37 CA248371/CA/NCI NIH HHS/United States GR - R01 CA185623/CA/NCI NIH HHS/United States GR - R01 CA100598/CA/NCI NIH HHS/United States GR - R01 CA098663/CA/NCI NIH HHS/United States GR - K07 CA201334/CA/NCI NIH HHS/United States GR - P30 CA072720/CA/NCI NIH HHS/United States PT - Journal Article DEP - 20230308 PL - Netherlands TA - Breast Cancer Res Treat JT - Breast cancer research and treatment JID - 8111104 RN - EC 2.7.1.1 (MTOR protein, human) RN - 0 (Receptors, Estrogen) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) RN - 0 (EIF4E protein, human) RN - EC 2.7.11.1 (AKT1 protein, human) SB - IM MH - Female MH - Humans MH - Black or African American MH - *Breast Neoplasms/etiology/genetics MH - Case-Control Studies MH - Exercise MH - Genetic Association Studies MH - Genetic Predisposition to Disease MH - Polymorphism, Single Nucleotide MH - Receptors, Estrogen/genetics/metabolism MH - Risk Factors MH - TOR Serine-Threonine Kinases/genetics PMC - PMC10695183 MID - NIHMS1944147 OTO - NOTNLM OT - Black women OT - Breast cancer OT - Effect modification OT - Physical activity OT - mTOR pathway COIS- Conflict of Interest The authors declare that they have no conflict of interest EDAT- 2023/03/08 06:00 MHDA- 2023/05/01 06:42 PMCR- 2024/05/01 CRDT- 2023/03/07 23:26 PHST- 2023/01/06 00:00 [received] PHST- 2023/02/17 00:00 [accepted] PHST- 2023/05/01 06:42 [medline] PHST- 2023/03/08 06:00 [pubmed] PHST- 2023/03/07 23:26 [entrez] PHST- 2024/05/01 00:00 [pmc-release] AID - 10.1007/s10549-023-06902-6 [pii] AID - 10.1007/s10549-023-06902-6 [doi] PST - ppublish SO - Breast Cancer Res Treat. 2023 May;199(1):137-146. doi: 10.1007/s10549-023-06902-6. Epub 2023 Mar 8.